United States Thromboplastin Market Report 2017

February 2017 | 118 pages | ID: U2C9E221B21EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Thromboplastin

Revenue, means the sales value of Thromboplastin

This report studies sales (consumption) of Thromboplastin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer AG
• Pfizer Inc
• Merck
• Sanofi
• Abbott Laboratories
• Johnson&Johnson
• Armetheon Inc
• Microbix Biosystems Inc
• Biovascular Inc
• Baxter International
• Astrazeneca
• Genentech
• Boehringer Ingelheim Gmbh
• Bristol-Myers Squibb CO
• CSL Behring
• ELI LILLY
• Emisphere Technologies
• Sun Pharmaceuticals
• Shire Pharmaceuticals

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Thromboplastin in each application, can be divided into

• Application 1
• Application 2

Contents

United States Thromboplastin Market Report 2017

1 THROMBOPLASTIN OVERVIEW

1.1 Product Overview and Scope of Thromboplastin
1.2 Classification of Thromboplastin
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Thromboplastin
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Thromboplastin (2012-2022)
  1.4.1 United States Thromboplastin Sales and Growth Rate (2012-2022)
  1.4.2 United States Thromboplastin Revenue and Growth Rate (2012-2022)

2 UNITED STATES THROMBOPLASTIN COMPETITION BY MANUFACTURERS

2.1 United States Thromboplastin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Thromboplastin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Thromboplastin Average Price by Manufactures (2015 and 2016)
2.4 Thromboplastin Market Competitive Situation and Trends
  2.4.1 Thromboplastin Market Concentration Rate
  2.4.2 Thromboplastin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES THROMBOPLASTIN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Thromboplastin Sales and Market Share by States (2012-2017)
3.2 United States Thromboplastin Revenue and Market Share by States (2012-2017)
3.3 United States Thromboplastin Price by States (2012-2017)

4 UNITED STATES THROMBOPLASTIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Thromboplastin Sales and Market Share by Type (2012-2017)
4.2 United States Thromboplastin Revenue and Market Share by Type (2012-2017)
4.3 United States Thromboplastin Price by Type (2012-2017)
4.4 United States Thromboplastin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES THROMBOPLASTIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Thromboplastin Sales and Market Share by Application (2012-2017)
5.2 United States Thromboplastin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES THROMBOPLASTIN MANUFACTURERS PROFILES/ANALYSIS

6.1 Bayer AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Thromboplastin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer AG Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer Inc
  6.2.2 Thromboplastin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Thromboplastin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Thromboplastin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott Laboratories
  6.5.2 Thromboplastin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Laboratories Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Johnson&Johnson
  6.6.2 Thromboplastin Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson&Johnson Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Armetheon Inc
  6.7.2 Thromboplastin Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Armetheon Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Microbix Biosystems Inc
  6.8.2 Thromboplastin Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Microbix Biosystems Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biovascular Inc
  6.9.2 Thromboplastin Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biovascular Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Baxter International
  6.10.2 Thromboplastin Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Baxter International Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Astrazeneca
6.12 Genentech
6.13 Boehringer Ingelheim Gmbh
6.14 Bristol-Myers Squibb CO
6.15 CSL Behring
6.16 ELI LILLY
6.17 Emisphere Technologies
6.18 Sun Pharmaceuticals
6.19 Shire Pharmaceuticals

7 THROMBOPLASTIN MANUFACTURING COST ANALYSIS

7.1 Thromboplastin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Thromboplastin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Thromboplastin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Thromboplastin Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES THROMBOPLASTIN MARKET FORECAST (2017-2022)

11.1 United States Thromboplastin Sales, Revenue Forecast (2017-2022)
11.2 United States Thromboplastin Sales Forecast by Type (2017-2022)
11.3 United States Thromboplastin Sales Forecast by Application (2017-2022)
11.4 Thromboplastin Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Thromboplastin
Table Classification of Thromboplastin
Figure United States Sales Market Share of Thromboplastin by Type in 2015
Table Application of Thromboplastin
Figure United States Sales Market Share of Thromboplastin by Application in 2015
Figure United States Thromboplastin Sales and Growth Rate (2012-2022)
Figure United States Thromboplastin Revenue and Growth Rate (2012-2022)
Table United States Thromboplastin Sales of Key Manufacturers (2015 and 2016)
Table United States Thromboplastin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thromboplastin Sales Share by Manufacturers
Figure 2016 Thromboplastin Sales Share by Manufacturers
Table United States Thromboplastin Revenue by Manufacturers (2015 and 2016)
Table United States Thromboplastin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Thromboplastin Revenue Share by Manufacturers
Table 2016 United States Thromboplastin Revenue Share by Manufacturers
Table United States Market Thromboplastin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Thromboplastin Average Price of Key Manufacturers in 2015
Figure Thromboplastin Market Share of Top 3 Manufacturers
Figure Thromboplastin Market Share of Top 5 Manufacturers
Table United States Thromboplastin Sales by States (2012-2017)
Table United States Thromboplastin Sales Share by States (2012-2017)
Figure United States Thromboplastin Sales Market Share by States in 2015
Table United States Thromboplastin Revenue and Market Share by States (2012-2017)
Table United States Thromboplastin Revenue Share by States (2012-2017)
Figure Revenue Market Share of Thromboplastin by States (2012-2017)
Table United States Thromboplastin Price by States (2012-2017)
Table United States Thromboplastin Sales by Type (2012-2017)
Table United States Thromboplastin Sales Share by Type (2012-2017)
Figure United States Thromboplastin Sales Market Share by Type in 2015
Table United States Thromboplastin Revenue and Market Share by Type (2012-2017)
Table United States Thromboplastin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Thromboplastin by Type (2012-2017)
Table United States Thromboplastin Price by Type (2012-2017)
Figure United States Thromboplastin Sales Growth Rate by Type (2012-2017)
Table United States Thromboplastin Sales by Application (2012-2017)
Table United States Thromboplastin Sales Market Share by Application (2012-2017)
Figure United States Thromboplastin Sales Market Share by Application in 2015
Table United States Thromboplastin Sales Growth Rate by Application (2012-2017)
Figure United States Thromboplastin Sales Growth Rate by Application (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Thromboplastin Sales Market Share (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc Thromboplastin Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Thromboplastin Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Thromboplastin Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Thromboplastin Sales Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson&Johnson Thromboplastin Sales Market Share (2012-2017)
Table Armetheon Inc Basic Information List
Table Armetheon Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Armetheon Inc Thromboplastin Sales Market Share (2012-2017)
Table Microbix Biosystems Inc Basic Information List
Table Microbix Biosystems Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Microbix Biosystems Inc Thromboplastin Sales Market Share (2012-2017)
Table Biovascular Inc Basic Information List
Table Biovascular Inc Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biovascular Inc Thromboplastin Sales Market Share (2012-2017)
Table Baxter International Basic Information List
Table Baxter International Thromboplastin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Baxter International Thromboplastin Sales Market Share (2012-2017)
Table Astrazeneca Basic Information List
Table Genentech Basic Information List
Table Boehringer Ingelheim Gmbh Basic Information List
Table Bristol-Myers Squibb CO Basic Information List
Table CSL Behring Basic Information List
Table ELI LILLY Basic Information List
Table Emisphere Technologies Basic Information List
Table Sun Pharmaceuticals Basic Information List
Table Shire Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thromboplastin
Figure Manufacturing Process Analysis of Thromboplastin
Figure Thromboplastin Industrial Chain Analysis
Table Raw Materials Sources of Thromboplastin Major Manufacturers in 2015
Table Major Buyers of Thromboplastin
Table Distributors/Traders List
Figure United States Thromboplastin Production and Growth Rate Forecast (2017-2022)
Figure United States Thromboplastin Revenue and Growth Rate Forecast (2017-2022)
Table United States Thromboplastin Production Forecast by Type (2017-2022)
Table United States Thromboplastin Consumption Forecast by Application (2017-2022)
Table United States Thromboplastin Sales Forecast by States (2017-2022)
Table United States Thromboplastin Sales Share Forecast by States (2017-2022)